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Background. The HIV Prevention Trials Network (HPTN) 052 trial demonstrated that early initiation of
antiretroviral therapy (ART) reduces human immunodeficiency virus (HIV) transmission from HIV-infected adults
(index participants) to their HIV-uninfected sexual partners. We analyzed HIV from 38 index-partner pairs and 80
unrelated index participants (controls) to assess the linkage of seroconversion events.
Methods. Linkage was assessed using phylogenetic analysis of HIV pol sequences and Bayesian analysis of
genetic distances between pol sequences from index-partner pairs and controls. Selected samples were also analyzed
using next-generation sequencing (env region).
Results. In 29 of the 38 (76.3%) cases analyzed, the index was the likely source of the partner’s HIV infection
(linked). In 7 cases (18.4%), the partner was most likely infected from a source other than the index participant
(unlinked). In 2 cases (5.3%), linkage status could not be definitively established.
Conclusions. Nearly one-fifth of the seroconversion events in HPTN 052 were unlinked. The association of
early ART and reduced HIV transmission was stronger when the analysis included only linked events. This
underscores the importance of assessing the genetic linkage of HIV seroconversion events in HIV prevention studies
involving serodiscordant couples.
Human immunodeficiency virus (HIV) from 2 in-
dividuals who are linked through transmission shares
more genetic homology than does HIV from unrelated
individuals. Therefore, genetic analysis of HIV from
different individuals can be used to assess the linkage of
HIV infections [1]. This approach has been used to
identify clusters of HIV infections in clinical trials [2, 3]
and was recently used to evaluate linkage of serocon-
version events in serodiscordant couples enrolled in an
HIV prevention trial [4, 5]. In that trial, 26.5% of the
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HIV seroconversion events were unlinked (ie, the partner likely
acquired HIV infection from a source other than the HIV-in-
fected participant) [4]. The frequency with which unlinked
events occur in serodiscordant couples is likely to vary between
populations and is likely to be influenced by social norms, be-
havioral factors, host and viral factors that influence infectivity
and susceptibility to infection, interventions used for HIV
prevention, and other factors.
The HIV Prevention Trials Network (HPTN) 052 is a multi-
center, phase III, randomized clinical trial designed to test
whether early initiation of antiretroviral therapy (ART) reduces
transmission from HIV-infected adults to their HIV-uninfected
sexual partners. On 28 April 2011, an independent data safety
and monitoring board (DSMB) determined that trial results
from an interim analysis adequately demonstrated a prevention
benefit of early ART initiation and a treatment benefit of early
ART to HIV-infected index participants. The DSMB recom-
mended release of the primary study results, which are described
elsewhere [6]. Thirty-nine seroconversion events occurred
during follow-up in HPTN 052 by the April 2011 DSMB
meeting; 1 of those events occurred shortly before the DSMB,
and samples were not available for analysis. Analysis was per-
formed to assess the genetic linkage of HIV in the remaining 38
seroconversion events. On the basis of data available at the time
of the DSMB meeting, the difference in HIV transmission in the
immediate study arm versus the delayed ART study arm based
on linked events was highly statistically significant (hazard ratio,
0.04; 95% confidence interval [CI],,.01 to .27; P , .001). This
report presents the methods and results used to assess the
linkage of HIV seroconversion events in HPTN 052 and the
association of demographic, behavioral, and clinical factors as-
sociated with linked versus unlinked HIV infection. This report
includes results from work performed both before and after the
April 2011 DSMB meeting, as noted.
METHODS
Samples Used for Analysis
HPTN 052 enrolled serodiscordant couples (index-partner pairs;
97% heterosexual). At screening, HIV-infected index partic-
ipants were ART naive, had a CD4 cell count of 350–550 cells/
mm3, and did not require ART for their own health according to
local, country-specific guidelines. Partners were HIV uninfected
at screening. Enrolled couples were randomized to initiate ART
in the index at the time of enrollment (immediate arm) or to
initiate ART in the index when 2 consecutive CD4 cell counts
were #250 cells/mm3 or an AIDS-defining illness developed
(delayed arm). From April 2005 through May 2010, 1763 cou-
ples with an HIV-infected partner were enrolled at 13 study sites
in Africa, Asia, and North and South America. Couples agreed to
be followed up for at least 5 years, with HIV testing of the
uninfected partner performed at regular intervals [6].
Samples were available for analysis from 38 of 39 serocon-
version events that occurred prior to the April 2011 DSMB
meeting (Table 1). Samples from randomly selected index
participants were analyzed for comparison (control samples).
Ten control samples were analyzed for each study site, with 2
exceptions: control samples were not available from the site in
the United States because of limited enrollment, and a total of 10
control samples were analyzed from 3 sites in Brazil.
Table 1. Analysis of Genetic Linkage of HIV From Index-Partner Pairs









Region Events Subtype Samplesa Linked Unlinked Linked Unlinked Linked Unlinked ND Linked Unlinked TBD
Africa 31 C 50 25 6 22 9 3 5 2 24 5 2
Asia 3 C/AE 20 2 1 2 1 1 2 1
Americae 4 B/F 10 3 1 3 1 1 3 1
38f 80 30 8 27 11 3 7 2 29 7 2
Abbreviations: AE, CRF01_AE; HIV, human immunodeficiency virus; ND, not determined; NGS, next-generation sequencing SC, seroconversion events; TBD, to be
determined.
a Sequences from subtype-matched local control samples were used for analysis; those samples were obtained from randomly selected index participants at the
same study sites. There were no subtype F controls and no controls for the site in the United States.
b Phylogenetic analysis was performed using HIV pol sequences obtained by population sequencing. Sequences from the same individual grouped together in all
cases with bootstraps of 100%. Events were considered to be linked if all of the samples from an index-partner pair grouped together on a single, unique branch; in
all but 1 case, the cluster of linked sequences had a bootstrap of 100%; in 1 case, the bootstrap was 99%.
c Bayesian analysis was performed by comparing genetic similarity values obtained by comparing pol sequences from seroconversion events (index and partner
sequences) and sequences from local control samples (samples from randomly selected index participants from the same study site).
d Results are the same as those available at the time of the April 2011 data safety monitoring board (DSMB) meeting, with 1 exception: linkage of 1 seroconversion
event that was provisionally characterized as unlinked by phylogenetic and Bayesian analysis of pol region sequences was subsequently determined to be linked by
NGS of the env region (Figure 4).
e ‘‘Americas’’ is defined as the United States and Brazil.
f Thirty-nine seroconversion events occurred prior to the date for data cutoff for the DSMB meeting. Samples from 1 event that occurred close to the time of the
April 2011 DSMB meeting were not available for analysis.
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Phylogenetic Analysis of HIV pol Sequences
Samples were analyzed using the ViroSeq HIV Genotyping
System (Celera). This system provides a consensus sequence of
the viral population (pol region) that encodes all 99 amino acids
in HIV protease and the first 335 amino acids in HIV reverse
transcriptase [7]. The system includes a contamination con-
trol system [8] and does not use nested polymerase chain
reaction (PCR), which has been associated with sample cross-
contamination [9]. Seven samples were amplified using alternate
amplification primers.
Pol region sequences (1302 nucleotides) from index-partner
pairs and local control samples were aligned with reference se-
quences recommended for HIV-1 subtype analysis (http://
hiv-web.lanl.gov/) with use of MegAlign software, version 5.07
(ClustalW alignment method). Distances between sequences
were calculated with DNADIST, and phylogenetic trees with
bootstrap support were inferred using neighbor-joining and
consense (PHYLIP, version 3.69; http://evolution.genetics.
washington.edu/phylip.html). The Kimura 2-parameter model
was used with a transition/transversion ratio of 1.5, im-
plemented in DNADIST. Bootstrap values .80% were consid-
ered acceptable for subtype assignment. Results obtained with
the Kimura-2-parameter model were compared with results
obtained using the ML (F84) model [10] implemented in
DNADIST. Phylogenetic trees were also generated using maxi-
mum likelihood criterion implemented in GARLI version 2 [11].
Trees were generated for each geographic region with use of
MegAlign, version 5.07; region-specific trees included pol se-
quences from the relevant index-partner pairs, subtype-matched
local control sequences, and subtype-matched reference se-
quences. A seroconversion event was classified as linked if the
index and partner sequences grouped together on a mono-
phyletic branch with a high bootstrap value.
Bayesian Analysis of HIV Linkage
We developed an algorithm based on Bayes’ theorem [4] to
estimate the probability of linkage of seroconversion events
based on the analysis of sequences from those events and se-
quences from epidemiologically related and unrelated in-
dividuals. Genetic similarity (percentage identity) between
paired pol sequences (index, partner, and control sequences) was
calculated using MegAlign, version 5.07. Genetic similarity was
computed between all possible pairs of sequences, including (i)
pairs of sequences from samples collected at different study visits
from a single individual, (ii) pairs of sequences from unrelated
index participants (control sequences from the same study site
or region), and (iii) pairs of sequences from index-partner pairs.
We assumed that pairs of sequences from unrelated index par-
ticipants were unlinked. Therefore, we used the genetic simi-
larities of the control sequences (type ii) to estimate the
distribution of percentage identity between known unlinked
sequence pairs. Furthermore, we assumed that the distribution
of similarities between 2 sequences from the same individual
(type i) was similar to the distribution of similarities in linked
index-partner pairs. We refer to the type (i) and type (ii) se-
quence pairs as the training data. We then used Bayes’ theorem
to compute the posterior probability of linkage for the unknown
























where Yi and si represent the linkage status (1 5 linked;
0 5 unlinked) and genetic similarity, respectively, for sequence
pair i; f0(s) and f1(s) give the density for a similarity s among
unlinked and linked sequences, respectively (estimated from the
training data) and p0 is the prior probability of linkage (p0 was
taken as the overall proportion of linked transmissions among
the 38 observed transmissions, making the process iterative)
(Supplementary File 1).
We used kernel density estimation to estimate f0 and f1 from
training data [12]. It is unclear how widely the distributions of
similarity vary across sites, HIV subtypes, or other factors.
Therefore, we computed 2 probabilities for each sequence pair:
unpooled probabilities, which computed f0 and f1 based on
training data from the same site as the sequence pair of interest,
and pooled probabilities, which computed f0 and f1 based on
pooling all subtype C data (for subtype C sequences) or all data
(for non–subtype C sequences). Because the pooled estimates of
f0 and f1 are more stable (ie, based on larger numbers), we based
our conclusions regarding linkage on the pooled results,
although the results were qualitatively similar in the 2 analyses.
Couples with probability of linkage $0.5 for any sequence pair
were provisionally categorized as linked; couples with proba-
bility of linkage ,0.5 for all sequence pairs were provisionally
categorized as unlinked.
Analysis of HIV env by Next-Generation Sequencing
Selected samples were analyzed using next-generation sequenc-
ing (NGS) [13, 14], as described elsewhere [15]. A combined
reverse-transcription polymerase chain reaction (PCR) was used
to amplify a region of gp41 (HXB2 coordinates: 7691–8374).
A nested PCR reactionwas then performed using primer sets that
included DNA barcodes for sample identification in NGS. PCR
products were analyzed using gel electrophoresis to confirm
successful amplification and were purified with the Amplicon
Library Preparation Method (Roche). Amplicon pools were
prepared by combining 5 lL of each diluted barcoded template
to make library pools that contained 14 barcoded amplicons
(1 3 109 molecules/lL). Templated beads were prepared for
NGS using the emPCR Method Manual-Lib-L-MV (Roche).
Library pools were diluted to 1 3 105 molecules/lL for a target
addition of 0.175 copies per bead to the DNA Capture Beads.
Enriched DNA Capture Beads were sequenced on the Roche
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454 instrument (Roche), according to the manufacturer’s
instructions, with use of a 4-region gasket.
Consensus sequences were generated using GS Amplicon
Variant Analyzer, version 2.5 (Roche), according to the manu-
facturer’s recommendations. Consensus sequences that were
within 10 bases from both ends of the amplicon and comprised
a cluster of $10 individual reads were retained in the
analysis. Consensus sequences and subtype reference sequences
were aligned using ClustalW [16]. Merged phylogenetic trees
were generated by the neighbor-joining method, using all
available consensus sequences from each index-partner and
subtype reference sequences. Statistical support for subtype
assignment was obtained by bootstrapping (500 replicates).
A seroconversion event was considered linked if all available
index and partner samples contained multiple consensus
sequences that grouped together with a high bootstrap value.
Analysis of Factors Associated With Linked and Unlinked
Seroconversion Events
Fisher exact test was used to assess the association between
linkage and categorical variables; Wilcoxon rank-sum test was
used to compare the time from enrollment to seroconversion
between linked and unlinked transmissions. All P values are
2-sided.
GenBank Accession Numbers
Accession numbers for population sequencing (HIV pol) were
JN247047–JN247075 (sequences analyzed in Figure 2) and
JN634296–JN634492 (other sequences) and for NGS (HIV env)
were JN371773–JN374672.
General Considerations
Personnel who performed the linkage studies were blinded to
the study arm assignments of study participants. Laboratory and
statistical analyses were performed independently. After the
28 April 2011 DSMB meeting, all of the data were further re-
viewed by 3 external experts who were also blinded to study arm
assignments.
Informed Consent
Human experimental guidelines of the US Department of
Health and Human Services and those of the authors’
institutions were followed in the conduct of this research.
Ethical review committees at each local and collaborating
organization approved the HPTN 052 trial, and the trial
was registered in ClinicalTrials.gov (NCT00074581). Written
informed consent was obtained from all study participants.
RESULTS
An overview of the methods used to assess the genetic linkage of
seroconversion events in HPTN 052 is shown in Figure 1. HIV
pol region sequences were obtained for 2 samples from different
study visits for 70 of the 76 participants (92.1%) studied (38
index-partner pairs); 3 index participants and 3 partners had
only 1 pol sequence result. The median time between collection
of the 2 partner samples was 27 days (range, 1–126 days), the
median time between collection of the 2 index samples was
356 days (range, 27–1211 days), and the median time between
collection of the earliest index sample and the latest partner
sample was 380 days (range, 1–1211 days); in some cases, the
second index sample was collected after the seroconversion
event. A single phylogenetic tree was generated using all available
index and partner sequences, 80 local control sequences, subtype
reference sequences, and an outgroup sequence (simian im-
munodeficiency virus). In all cases, paired sequences from the
same individual grouped closely together on monophyletic
branches; the median genetic similarity of the paired sequences
was 99.5% (range, 94.7%–100%). For all 38 index-partner pairs,
the HIV subtype of the index and partner was the same and was
consistent with the prevalent subtype(s) in the region (Table 1).
Antiretroviral drug resistance mutations were detected in sam-
ples from 4 index-partner pairs. In all 4 cases, the pattern of
resistance mutations detected was consistent with the final
linkage assessment (Supplementary File 2). Phylogenetic trees
were also generated for each geographic region (Africa, Asia,
and North and South America). The phylogenetic clustering of
sequences from index-partner pairs was the same in the large
composite tree and the region-specific trees (not shown).
A representative tree that includes 5 seroconversion events is
shown (Figure 2).
Figure 1. Outline of approach used for linkage analysis (see text).
HIV Transmission Linkage: HPTN 052 d JID 2011:204 (15 December) d 1921
In 30 of the 38 couples analyzed, the sequence(s) obtained for
the index grouped with the sequence(s) obtained for the cor-
responding partner on a unique, monophyletic branch. The
bootstrap values for the grouped sequences were 100% in all but
1 case (for 1 event, the bootstrap value was 99%). Those 30
seroconversion events were provisionally characterized as
linked. In the remaining 8 couples, sequences from the index
and partner did not group together. Those 8 seroconversion
events were provisionally characterized as unlinked. There was
no difference in the linkage assessments using other models for
determining genetic distance (see Materials and Methods).
The genetic linkage of HIV from index-partner pairs was also
assessed by comparing genetic similarity of paired HIV pol
sequences using Bayesian analysis. A posterior probability of
linkage was computed for each index-partner sequence pair
(up to 4 sequences per couple) using pooled and unpooled
training data (Figure 3). Pooled results were used for the pri-
mary determination of linkage. Using this approach, 27 of the
38 (71%) seroconversion events were classified as linked and 11
as unlinked.
In 35 of the 38 (92.1%) seroconversion events analyzed, the
linkage assessments based on phylogenetic and Bayesian analyses
were concordant (Table 1). In 27 cases, both were linked; in
8 cases, both were unlinked. In the remaining 3 cases, phylo-
genetic analysis suggested that the seroconversion events were
linked, whereas statistical analysis suggested that they were not
linked; those events were provisionally characterized as ‘‘to be
determined’’ (TBD). Examples of results from phylogenetic and
Bayesian analyses are shown in Table 2.
Samples from 12 of the 38 (31.6%) seroconversion events
were further analyzed using NGS (env region [gp41]). This in-
cluded 1 event provisionally characterized as linked, 8 events
Figure 2. Example of phylogenetic analysis of pol sequences from index-partner pairs. A phylogenetic tree was generated for 5 seroconversion events
from Africa. The tree includes sequences from index participants and their partners (colored text: I, index; P, partner). Sequences from 2 different study
visits were available for 9 of the 10 participants analyzed (A, sequence from the index or partner collected at the earlier study visit; B, sequence from the
index or partner collected at the later study visit). The tree also includes subtype-matched reference sequences (C, ref), 10 local control sequences
(randomly selected index participants from the same study site [blue dots] ) and an outgroup sequence (CPZ.GA.CPZGAB, SIV). Bootstrap values are shown
for the grouping of index and partner sequences for each event based on 500 bootstrap replications. In all cases, paired sequences from a given
participant grouped together. In 4 cases, all of the sequences from a given event (all index and partner sequences from an index-partner pair) grouped on
a single branch with a bootstrap value of 100% (052-1692, 052-2899, 052-0621, and 052-2337), indicating that the events were linked. In 1 case, the 2
sequences from the index did not group with the 2 sequences from the partner (052–3172), indicating that the event was unlinked.
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provisionally characterized as unlinked, and 3 events pro-
visionally characterized as TBD. NGS analysis confirmed that 7
of the 8 provisionally unlinked events were unlinked. However,
for 1 event that was provisionally classified as unlinked, NGS
analysis revealed that the event was linked (event 052-2989;
Figure 4A). NGS results for 1 event provisionally characterized
as TBD indicated that the event was linked. NGS results for the
other 2 TBD events did not sufficiently meet the criteria estab-
lished for linkage; the status for those events was not changed.
One sample provisionally characterized as linked was confirmed
to be linked by NGS.
Final linkage status was determined for 36 of the 38 events
analyzed (Table 1). In all but 1 case, the final linkage assessment
was the same as the assessment made based on data available at
the time of the April 2011 DSMB meeting. In 1 case, a sero-
conversion event in the delayed ART study arm that was pre-
viously characterized as TBD was subsequently characterized as
linked (event 052-1168; Figure 4B).
The median minimum time between collection of index
and partner samples was 28 days (interquartile range [IQR],
0–84 days; range, 0–1083 days) and was longer for the 7 un-
linked events (median, 266 days; IQR, 180–537 days; range,
77–696 days) than for the 29 linked events (median, 4.0 days;
IQR, 0–66 days; range, 0–1083 days). Nonetheless, the range of
time between paired index specimens (median, 355 days; IQR,
178–503 days), for which 29 of 30 similarities were .97%, was
similar to the range of time between unlinked index-partner
samples, all of which had similarities ,95%. This suggests that
the timing of specimen collection did not significantly influence
the final linkage assessment.
We analyzed the association of demographic, behavioral, and
clinical factors with the linkage status of seroconversion events
(Table 3). Linked HIV transmission was more frequent when the
index participant was in the delayed ART study arm and was not
receiving ART at the time of the partner’s seroconversion. There
was also a significant association between unlinked transmission
Figure 3. Densities of similarities from linked and unlinked sequence pairs. A, Densities of similarities from linked and unlinked sequence pairs
from 32 subtype C couples, along with subtype C training data. B, Densities of similarities from linked and unlinked sequence pairs from 6 couples with
non–subtype C human immunodeficiency virus (HIV) infection, along with non-subtype C unlinked training data and all linked training data (there were
insufficient data to estimate a non-subtype C linked density).
Table 2. Representative Results Obtained From Linkage Analysisa
Seroconversion event identification number
Linkage criterionb 052-1692 052-2899 052-0621 052-3172 052-2377
No. of available samples 4 3 4 4 4
Phylogenetic clustering Grouped Grouped Grouped Not grouped Grouped
Bootstrap value 100% 100% 100% ND 100%
Sequence similarity 98.2–98.5 97.9–98.0 96.9–98.5 92.2 98.5
Bayesian posterior probability, pooled 1.00 0.99–1.00 0.94–1.00 0.00 1.00
Bayesian posterior probability, unpooled 1.00 1.00 0.99–1.00 0.00 1.00
Final linkage assessment Linked Linked Linked Unlinked Linked
a Results are shown from analysis of 5 seroconversion events from Africa (the same events included in Figure 2).
b No. available sequences indicates the total number of index and partner samples available for the analysis of each seroconversion event; the number 4 indicates
that samples were available for 2 different study visits for both the index and the partner. Phylogenetic clustering: ‘‘Grouped’’ indicates that all available index and
partner sequences were grouped together on a single, unique branch. ‘‘Not grouped’’ indicates that the sequences from the partner did not group with the
sequences from the index participant. Bootstrap values are for the grouping of index and partner sequences. A bootstrap value was not determined for the unlinked
event (052-3172, not determined [ND]); that event was confirmed to be unlinked based on results from next-generation sequencing.
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and the partner’s report of a higher number of sexual partners
during the 3 months before seroconversion. We did not find an
association between linked transmission and geographic region
(Africa, Asia, and America), index sex, index CD4 cell count at
the time of the partner’s seroconversion, or the length of time
between enrollment and seroconversion. Linked transmission
was less frequent in male–male couples. However, there were
only 2 male–male couples in the analysis.
DISCUSSION
At the time of the April 2011 DSMB meeting, 39 seroconversion
events had been documented in the HPTN 052 trial. Linkage
status was determined for 36 of 39 events (linkage status of 2
events could not be definitively determined; samples from 1
event were not available for analysis). For 7 of the 36 (19.4%)
seroconversion events for which linkage was established, the
partner likely acquired HIV infection from a source other than
the index participant. This frequency of unlinked events is lower
than that observed in the Partners in Prevention trial (26.5%),
which enrolled serodiscordant couples in 7 sub-Saharan African
countries [4], and is higher than that observed in a cohort of
serodiscordant couples from Zambia (13%) [17]; however, none
of these differences is statistically significant.
The primary linkage analysis in this study was based on HIV
pol sequences that have been used previously for HIV linkage
studies [14–17]. Data from this study indicate that there was
sufficient genetic diversity in the pol region among participants
in HPTN 052 to discriminate between linked and unlinked HIV
infections. This is apparent from the posterior probability val-
ues, most of which were very close to 0 (definitely unlinked) or 1
(definitely linked), and from the very limited overlap in the
distribution of genetic similarities (Figure 3). The pol region
generally has a low rate of genetic diversification during HIV
infection. This was important because the collection dates of
samples used for the analysis of some index-partner pairs dif-
fered by .1 year. Data from this study indicate that genetic
distance increased in the region analyzed by only 0.65% per year.
Very few drug resistance mutations were detected in the se-
quences analyzed (Supplementary File 2). Analysis of 2 in-
dependent samples from each study participant and inclusion of
local control samples obtained from randomly selected index
Figure 4. Next-generation sequencing results for the env region (gp41). The figure shows phylogenetic trees generated using data from next-
generation sequencing (NGS, env region [gp41]). Each panel shows results obtained for 1 seroconversion event where linkage of the index and partner
was established based on NGS data. Merged neighbor-joining trees were constructed using subtype reference sequences (black text, subtypes A, B, C,
and D) and gp41 consensus NGS sequences from the relevant index participant (2 samples) and partner (2 samples). Note that only consensus sequences
with$10 primary NGS reads were used. Color-coding indicates sequences from individual samples (red, index sample 1; pink, index sample 2; dark blue,
partner sample 1; teal, partner sample 2). Bootstrap values are shown for selected branches (percentage of trees where the sequences group together,
among 500 trees generated). Genetic distance is shown (scale line ). A, Data for the seroconversion event from couple 052-2989. For this event, the
second index sample was collected 1211 days after the first index sample; the partner samples were collected 1169 and 1211 days after the first index
sample. The number of primary sequence reads per sample for these 4 samples ranged from 6555 to 13 696, and the number of consensus sequences per
sample for these 4 samples ranged from 35 to 108. This event was provisionally characterized as unlinked based on data obtained by phylogenetic and
Bayesian analysis of pol region sequences. The linkage status was changed to linked based on the results from NGS. B, Data for the seroconversion event
from couple 052-1168. For this event, the second index sample was collected 466 days after the first index sample; the partner samples were collected
539 and 556 days after the first index sample. The number of primary sequence reads per sample for these 4 samples ranged from 6891 to 11700,
and the number of consensus sequences per sample for these 4 samples ranged from 38 to 80. The linkage status of this event could not be determined
based on data obtained by phylogenetic and Bayesian analysis of pol region sequences. The linkage status was changed to linked based on the results
from NGS. This analysis was repeated using local control sequences in addition to subtype reference sequences. Both of these events (052-2989 and
052-1168) were from Malawi. The local control sequences used in the analysis of each event included the most prominent consensus sequence from
each of 22 other individuals enrolled in the HIV Prevention Trials Network (HPTN) 052. Twenty of the 22 individuals were from Africa and had subtype C
human immunodeficiency virus (HIV), and 12 of those individuals were from Malawi. The results obtained using subtype reference sequences only (A and
B ) or subtype reference sequences plus local control sequences (not shown) did not differ in any meaningful way.
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participants enrolled in HPTN 052 provided an additional level
of quality control for the linkage assessment.
In the Partners in Prevention study, unlinked events were
more frequent in couples in which the seroconverting partner
was male [4]. We did not find an association between linkage
and sex in HPTN 052. However, our ability to detect statistically
significant associations with sex and other factors may have been
limited by the small number of events examined (36 classifiable).
Of interest, ART use (in either the immediate or delayed
ART study arm) and viral suppression in the index case were
associated with a higher frequency of unlinked seroconversion
events. All 7 of the unlinked events occurred in couples in which
the index participant’s viral load was very low at the time
of the partner’s seroconversion (,400 copies/mL in 6 cases,
434 copies/mL in 1 case). This was somewhat surprising; the
probability of observing 6 of 7 or 7 of 7 suppressed index par-
ticipants among the unlinked seroconversion events by chance is
8.4%. As one might expect, there was a significant association
between unlinked transmission and a higher number of sexual
partners reported by the partner in the 3 months before HIV
seroconversion. The analysis of factors associated with linkage
of seroconversion events was based on a small number of se-
roconversion events (those that occurred before the DSMB
meeting that led to early release of the study results). This may
have limited the power to detect some associations. We cannot
determine whether any of the associations that we observed
would also be observed with longer follow-up or whether new
associations would be identified with longer follow-up of study
participants.
The impact of early ART on HIV transmission in HPTN 052
was analyzed for all 39 seroconversion events that occurred
before the DSMB meeting and for the subset of 28 linked events
identified at the time of the DSMB meeting [6]. When all 39
events were included in the analysis (4 in the immediate ART
arm, 35 in the delayed ART arm), the difference in HIV in-
cidence between the 2 study arms was highly statistically sig-
nificant (rate ratio, 0.114; exact 95% CI, .041–.321; P , .001).
When the analysis included only the 28 linked events (1 in the
immediate arm, 27 in the delayed arm), the association of the
study intervention (early ART) and transmission was even
Table 3. Factors Associated With Linkage of Seroconversion Events
Linked Unlinked P value
Region .60a
Africa 24 (83%) 5 (71%)
Asia/America 5 (17%) 2 (29%)
Index sex .39a
Male 10 (34%) 4 (57%)
Female 19 (66%) 3 (43%)
Couple type .033a
Male–male 0 (0%) 2 (29%)
Other 29 (100%) 5 (71%)
Index study arm .018a
Early ART 1 (3%) 3 (43%)
Deferred ART 28 (97%) 4 (57%)
Index on ART at time of SC .0076a
Yes 2b (7%) 4 (57%)
No 27 (93%) 3d (43%)
Index CD4 count at time of SC, median (IQR) 352 (283–468) 404 (301–540) .41c
Years between enrollment and serconversion, median (IQR) 1.0 (0.5–2.0) 2.0 (0.7–2.7) .25c
No. of sex partners in the 3 months before SCe ,.0001a
.1 0 (0%) 4 (57%)
1 26 (90%) 3 (43%)
0 2 (7%) 0 (0%)
Total 29 7
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range; SC, seroconversion; VL, viral load.
a P value from Fisher exact test.
b Two index participants in linked index-partner pairs were on ART at the time of that human immunodeficiency virus infection was documented in the partner (time
of seroconversion). One of these participants was in the immediate ART arm of the HIV Prevention Trials Network (HPTN) 052 trial and initiated ART at the time of
enrollment into the trial, approximately 3 months before the seroconversion event. The other index participant was in the delayed ART arm of the HPTN 052 trial and
initiated ART approximately 4 weeks before the seroconversion event.
c P value from Wilcoxon rank–sum test.
d One participant was on ART due to pregnancy. She was considered not to be taking ART at the time of her partner’s seroconversion.
e One participant in a linked seroconversion couple did not provide information about the number of sex partners in the 3 months before seroconversion.
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stronger (rate ratio, 0.04; exact 95% CI, .001–.27; P, .001) [6].
Data obtained after the DSMB meeting resulted in only 1 ad-
ditional linkage assignment: 1 seroconversion event in the de-
layed ART arm was characterized as linked. These additional
data further strengthen the association between early ART ini-
tiation and risk reduction of HIV transmission. Data from this
study and other recent studies [4, 17] indicate that a significant
proportion of seroconversion events in serodiscordant couples
may be unlinked. These findings underscore the importance of
assessing the genetic linkage of HIV in seroconversion events in
HIV prevention studies involving serodiscordant couples.
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